Every disease area comes with its own complexities in healthcare communications, but oncology operates on a different level. The science evolves at an extraordinary pace, the terminology is highly specialized, and treatment decisions can be deeply personal and time-sensitive.
Communicating in oncology requires fluency in the science, sensitivity to the human experience, and an understanding of how to translate both for different audiences—from patients and caregivers to oncologists, researchers, payers, and advocates—without sacrificing accuracy or clarity.
The science doesn’t stand still
At Speaking of Science, we’ve spent years learning, navigating, and communicating medical research, and few areas of medicine are advancing as rapidly as oncology.
In just the past decade, precision medicine has changed how many cancers are classified and treated, biomarker testing is helping identify which patients may benefit from particular therapies, and immunotherapies have introduced entirely new ways of treating certain cancers. Looking ahead, antibody-drug conjugates, targeted therapies, cell and gene therapies, radiopharmaceuticals, and other emerging approaches continue to expand the treatment landscape—all while our understanding of cancer biology continues to evolve.
For communicators, keeping pace isn’t optional. Today’s oncology communications may involve explaining a novel mechanism of action, interpreting clinical trial data, communicating the significance of a biomarker, or helping an audience understand where a new treatment fits within an increasingly complex standard of care.
Effective oncology communication begins with scientific fluency, and the challenge isn’t simply understanding the terminology. It’s understanding the science well enough to know what matters, and which questions will lead to meaningful answers. For example: What does a new endpoint mean for clinicians? Which piece of data is most relevant to a patient? How does a new therapy differ meaningfully from existing options? What context does an audience need before a finding makes sense?
Knowing your audience
The complexity of oncology communication is rooted in its many audiences. Because each audience brings different knowledge, priorities, questions, and emotional stakes, simply simplifying the same message isn’t enough.
Consider a new cancer therapy moving through clinical development. The same underlying science may need to reach:
- Researchers interested in the biological rationale and supporting evidence;
- Oncologists evaluating clinical data and its potential implications for practice;
- Payers considering value, outcomes, and the broader treatment landscape;
- Advocacy organizations looking at what a development could mean for their communities; and
- Patients and caregivers trying to understand what a treatment does and whether it might be relevant to them.
The job of a skilled oncology communicator is to identify what each audience needs to understand and translate the information accordingly, preserving the integrity of the underlying science.
That might mean turning dense clinical data into a clear scientific narrative for a conference presentation, or developing physician-facing materials that prioritize evidence and clinical relevance. Or it might mean explaining the same science to patients in language that is approachable and useful without being reductive. What’s important is that the science stays accurate, even when its presentation is adapted.
The weight of words in oncology
For patients and families, cancer information isn’t abstract. Shortly after a diagnosis, while considering treatment options, after learning that a therapy has stopped working, or while searching for information about a clinical trial—language matters.
Terms that are routine within the scientific community can be confusing or frightening outside it. Words like progression, response, risk, survival, and even positive can carry meanings in oncology that differ significantly from their everyday use.
Communicators also have to navigate uncertainty carefully. A promising early-stage result isn’t a proven treatment. An improvement in an endpoint doesn’t necessarily mean the same thing as a cure. Population-level statistics cannot predict exactly what will happen to an individual patient.
Good oncology communication makes complexity understandable, without eliminating complexity or uncertainty to make a message easier to deliver. And that requires precision, empathy, and restraint.
Clarity doesn’t sacrifice quality
One of the persistent misconceptions about scientific communication is that making something accessible means removing the science. At Speaking of Science, we know this isn’t the case. The best oncology communications don’t choose between scientific rigor and inclusive accessibility. They achieve both.
Firstly, a communicator must understand the material deeply enough to identify the essential story within it. From there, they can define unfamiliar terminology, establish context, use meaningful comparisons, structure information logically, and remove complexity that doesn’t serve the audience.
A lack of information can create miscommunication. This is particularly important in oncology, where oversimplification can distort meaning. A patient deserves information that is understandable without being patronizing. A physician deserves efficiency without losing scientific nuance. An investor or payer may need a different level of evidence and context altogether.
Plain language isn’t about making the science less sophisticated. It’s about making sophisticated science more usable.
Communication has to move as fast as the field
Oncology communications also happen across an unusually dynamic ecosystem.
A single program may generate communications around clinical trial recruitment, medical congresses, data readouts, regulatory milestones, publications, product launches, patient education, advocacy initiatives, and ongoing disease awareness. New findings can also change the context around existing messages quickly—competitive landscapes evolve, standards of care shift, new biomarkers emerge, regulatory decisions reshape treatment pathways.
As a result, oncology communicators can’t work from a static understanding of the field. They need to know the scientific and competitive landscape surrounding the story they’re telling. They need to recognize when new information changes the context. And they need to translate developments quickly without compromising accuracy. That’s where deep therapeutic-area experience becomes especially valuable.
Oncology expertise is communication expertise
Oncology expertise doesn’t end with cancer terminology. True experts know that overall survival and progression-free survival shouldn’t be treated interchangeably. They understand why biomarker status may fundamentally change the relevance of a study. They recognize that a statistically significant result and a clinically meaningful result aren’t necessarily the same thing.
They also know when those distinctions matter to the audience, and how to explain them when they do. That combination of scientific understanding and communications judgment is what turns information into effective communication.
After all, oncology will continue to become more sophisticated. New treatment modalities, biomarkers, technologies, and discoveries will create extraordinary opportunities. And new communications challenges along with them.
As science evolves, the need for clear, credible scientific communication will only grow. Organizations working in oncology need communications partners who can enter the conversation already understanding its language and its stakes. Partners who can move comfortably between scientific detail and plain language. Partners who recognize that patients, physicians, payers, advocates, researchers, and other stakeholders may all need something different from the same body of evidence.
We speak oncology
At Speaking of Science, we bring these capabilities together. We understand the science. We understand the audiences. And we understand that the way you communicate a discovery can be just as important as deciding what to communicate in the first place.
Our expert communicators translate complex oncology science into clear, credible communications built for the audience, the channel, and the moment. Because oncology isn’t just another healthcare vertical, and communicating it shouldn’t be treated like one.
